The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2020

Filed:

May. 16, 2018
Applicant:

Petvivo Holdings, Inc., Edina, MN (US);

Inventors:

David B. Masters, Minneapolis, MN (US);

Eric P. Berg, Plymouth, MN (US);

Assignee:

PETVIVO HOLDINS, INC., Edina, MN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/24 (2006.01); A61K 31/726 (2006.01); A61K 31/728 (2006.01); A61K 31/727 (2006.01); A61L 27/22 (2006.01); A61K 8/64 (2006.01); A61K 8/65 (2006.01); A61K 31/70 (2006.01); A61K 35/545 (2015.01); A61K 38/39 (2006.01); A61K 45/06 (2006.01); A61L 27/20 (2006.01); A61L 27/34 (2006.01); A61L 27/48 (2006.01); A61L 27/50 (2006.01); A61L 31/10 (2006.01); A61L 33/12 (2006.01); A61Q 19/08 (2006.01); A61K 31/715 (2006.01); A61M 25/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/24 (2013.01); A61K 8/64 (2013.01); A61K 8/65 (2013.01); A61K 31/70 (2013.01); A61K 31/715 (2013.01); A61K 31/726 (2013.01); A61K 31/727 (2013.01); A61K 31/728 (2013.01); A61K 35/545 (2013.01); A61K 38/39 (2013.01); A61K 45/06 (2013.01); A61L 27/20 (2013.01); A61L 27/22 (2013.01); A61L 27/227 (2013.01); A61L 27/34 (2013.01); A61L 27/48 (2013.01); A61L 27/507 (2013.01); A61L 31/10 (2013.01); A61L 33/12 (2013.01); A61Q 19/08 (2013.01); A61K 38/00 (2013.01); A61K 2800/91 (2013.01); A61M 25/0045 (2013.01);
Abstract

The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.


Find Patent Forward Citations

Loading…